Neuphoria Therapeutics Statistics
Total Valuation
NEUP has a market cap or net worth of $12.77 million. The enterprise value is -$4.16 million.
Important Dates
The next estimated earnings date is Friday, August 15, 2025, before market open.
| Earnings Date | Aug 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NEUP has 1.88 million shares outstanding. The number of shares has increased by 352.55% in one year.
| Current Share Class | 1.88M |
| Shares Outstanding | 1.88M |
| Shares Change (YoY) | +352.55% |
| Shares Change (QoQ) | +9.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 12.54% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 2.18.
| PE Ratio | 2.18 |
| Forward PE | n/a |
| PS Ratio | 0.81 |
| Forward PS | n/a |
| PB Ratio | 0.48 |
| P/TBV Ratio | 1.01 |
| P/FCF Ratio | 19.51 |
| P/OCF Ratio | 19.51 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.01, with a Debt / Equity ratio of 0.01.
| Current Ratio | 11.01 |
| Quick Ratio | 11.00 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 1.63 |
| Debt / FCF | 0.26 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 25.45% and return on invested capital (ROIC) is -1.25%.
| Return on Equity (ROE) | 25.45% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -1.25% |
| Return on Capital Employed (ROCE) | -1.61% |
| Revenue Per Employee | $652,613 |
| Profits Per Employee | $242,792 |
| Employee Count | 24 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -235,880 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 5.73 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 56.97 |
| Average Volume (20 Days) | 29,308 |
Short Selling Information
The latest short interest is 16,671, so 0.89% of the outstanding shares have been sold short.
| Short Interest | 16,671 |
| Short Previous Month | 20,311 |
| Short % of Shares Out | 0.89% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, NEUP had revenue of $15.66 million and earned $5.83 million in profits. Earnings per share was $0.00.
| Revenue | 15.66M |
| Gross Profit | 16.73M |
| Operating Income | -470,681 |
| Pretax Income | n/a |
| Net Income | 5.83M |
| EBITDA | -24,706 |
| EBIT | -470,681 |
| Earnings Per Share (EPS) | $0.00 |
Full Income StatementBalance Sheet
The company has $17.04 million in cash and $172,460 in debt, giving a net cash position of $16.87 million or $8.97 per share.
| Cash & Cash Equivalents | 17.04M |
| Total Debt | 172,460 |
| Net Cash | 16.87M |
| Net Cash Per Share | $8.97 |
| Equity (Book Value) | 26.00M |
| Book Value Per Share | 14.02 |
| Working Capital | 15.54M |
Full Balance SheetCash Flow
| Operating Cash Flow | 651,512 |
| Capital Expenditures | n/a |
| Free Cash Flow | 651,512 |
| FCF Per Share | $0.35 |
Full Cash Flow StatementMargins
Gross margin is 106.82%, with operating and profit margins of -3.01% and 37.20%.
| Gross Margin | 106.82% |
| Operating Margin | -3.01% |
| Pretax Margin | 35.70% |
| Profit Margin | 37.20% |
| EBITDA Margin | -0.16% |
| EBIT Margin | -3.01% |
| FCF Margin | 4.16% |
Dividends & Yields
NEUP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -352.55% |
| Shareholder Yield | -352.55% |
| Earnings Yield | 45.85% |
| FCF Yield | 5.13% |
Analyst Forecast
The average price target for NEUP is $21.00, which is 209.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.00 |
| Price Target Difference | 209.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NEUP has an Altman Z-Score of -5.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.65 |
| Piotroski F-Score | 2 |